Literature DB >> 11814530

Predictors of nonresponse to treatment in primary care patients with dysthymia.

Wayne Katon1, Joan Russo, Ellen Frank, James Barrett, John W Williams, Thomas Oxman, Mark Sullivan, John Cornell.   

Abstract

Dysthymia is one of the most prevalent problems in primary care, especially in the elderly. In this study, we evaluated the demographic and clinical predictors of nonresponse to treatment in primary care patients with dysthymia. The study sample consisted of 338 primary care patients meeting DSMIII-R criteria for dysthymia from 4 diverse geographic sites in a randomized controlled 11-week trial of paroxetine, problem-solving therapy or placebo. Patients who attended at least 4 treatment sessions were used in the analysis. A score of less than 7 on the Hamilton was defined as a positive response to treatment. By Week 11, 52.2% of patients had a positive response to treatment. Patients with lower levels of education (odds ratio 0.44, 95% CI 0.23, 0.86), higher scores on the personality dimension of neuroticism (odds ratio 0.58, 95% CI 0.36, 0.92) and those with more severe medical illness (odds ratio 0.97, 95% CI 0.95, 0.99) were less likely to recover with either active or placebo treatments. Elderly women (>60 years of age; odds ratio 0.19, 95% CI 0.05, 0.66) were also less likely to respond to all treatments; however, females had a significantly higher response to placebo treatment compared to males. The factors associated with lack of response to treatment included lower-levels of education, high neuroticism, more severe medical illness and being an older female. This analysis is based on patients agreeing to participate in a randomized controlled trial, limiting representativeness of the sample, however, the demographic and clinical characteristics are common in elderly depressed primary care patients, and may signal the need for increased mental health specialty consultation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814530     DOI: 10.1016/s0163-8343(01)00171-2

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  12 in total

1.  Neuroticism: a non-informative marker of vulnerability to psychopathology.

Authors:  Johan Ormel; Judith Rosmalen; Ann Farmer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-11       Impact factor: 4.328

2.  The impact of comorbid dysthymic disorder on outcome in personality disorders.

Authors:  David J Hellerstein; Andrew E Skodol; Eva Petkova; Hui Xie; John C Markowitz; Shirley Yen; John Gunderson; Carlos Grilo; Maria T Daversa; Thomas H McGlashan
Journal:  Compr Psychiatry       Date:  2010-01-08       Impact factor: 3.735

3.  Problem solving therapy for subthreshold depression in home healthcare patients with cardiovascular disease.

Authors:  Zvi D Gellis; Martha L Bruce
Journal:  Am J Geriatr Psychiatry       Date:  2010-06       Impact factor: 4.105

Review 4.  Brief psychotherapy for depression: a systematic review and meta-analysis.

Authors:  Jason A Nieuwsma; Ranak B Trivedi; Jennifer McDuffie; Ian Kronish; Dinesh Benjamin; John W Williams
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

5.  Improving depression care in patients with diabetes and multiple complications.

Authors:  Leslie S Kinder; Wayne J Katon; Evette Ludman; Joan Russo; Greg Simon; Elizabeth H B Lin; Paul Ciechanowski; Michael Von Korff; Bessie Young
Journal:  J Gen Intern Med       Date:  2006-07-07       Impact factor: 5.128

6.  Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression.

Authors:  Judith Weissman; Alastair Flint; Barnett Meyers; Samiran Ghosh; Benoit Mulsant; Anthony Rothschild; Ellen Whyte
Journal:  Psychiatry Res       Date:  2012-03-31       Impact factor: 3.222

7.  A randomized controlled trial of a close monitoring program for minor depression and distress.

Authors:  Jennifer T Ross; Thomas TenHave; April C Eakin; Suzanne Difilippo; David W Oslin
Journal:  J Gen Intern Med       Date:  2008-05-23       Impact factor: 5.128

8.  Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.

Authors:  Tracy L Hellem; Young-Hoon Sung; Xian-Feng Shi; Marjorie A Pett; Gwen Latendresse; Jubel Morgan; Rebekah S Huber; Danielle Kuykendall; Kelly J Lundberg; Perry F Renshaw
Journal:  J Dual Diagn       Date:  2015

Review 9.  Mechanisms of the placebo effect in pain and psychiatric disorders.

Authors:  R D Holmes; A K Tiwari; J L Kennedy
Journal:  Pharmacogenomics J       Date:  2016-03-22       Impact factor: 3.550

Review 10.  Incomplete response in late-life depression: getting to remission.

Authors:  Eric J Lenze; Meera Sheffrin; Henry C Driscoll; Benoit H Mulsant; Bruce G Pollock; Mary Amanda Dew; Frank Lotrich; Bernie Devlin; Robert Bies; Charles F Reynolds
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.